Cargando…
Nanofiber-expanded human umbilical cord blood–derived CD34(+) cell therapy accelerates cutaneous wound closure in NOD/SCID mice
Nanofiber-expanded human umbilical cord blood–derived CD34(+) cell therapy has been shown to have potential applications for peripheral and myocardial ischaemic diseases. However, the efficacies of expanded CD34(+) cell therapy for treating cutaneous wounds and its mechanisms of action have yet to b...
Autores principales: | Kanji, Suman, Das, Manjusri, Aggarwal, Reeva, Lu, Jingwei, Joseph, Matthew, Pompili, Vincent J, Das, Hiranmoy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981939/ https://www.ncbi.nlm.nih.gov/pubmed/24455991 http://dx.doi.org/10.1111/jcmm.12217 |
Ejemplares similares
-
Nanofiber-expanded human CD34(+) cells heal cutaneous wounds in streptozotocin-induced diabetic mice
por: Kanji, Suman, et al.
Publicado: (2019) -
Human Umbilical Cord Blood-Derived CD34(+) Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities
por: Aggarwal, Reeva, et al.
Publicado: (2012) -
Human Ovarian Tumor Cells Escape γδ T Cell Recognition Partly by Down Regulating Surface Expression of MICA and Limiting Cell Cycle Related Molecules
por: Lu, Jingwei, et al.
Publicado: (2011) -
Induction of Krüppel‐like factor 2 reduces K/BxN serum‐induced arthritis
por: Das, Manjusri, et al.
Publicado: (2018) -
Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer
por: Das, Hiranmoy, et al.
Publicado: (2013)